Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytosine deaminase (fungal) is an enzyme found in yeast and other fungi, but not in mammalian cells. It catalyzes the hydrolytic deamination of cytosine to uracil, thus playing a key role in the pyrimidine salvage pathway. Of special therapeutic relevance, it converts the prodrug 5-fluorocytosine to 5-fluorouracil, a potent cytotoxic molecule widely used in antifungal and anticancer applications. The enzyme is a zinc-dependent hydrolase, structurally distinct from its bacterial counterparts but mechanistically similar. Fungal cytosine deaminase is utilized in gene-directed enzyme prodrug therapy (GDEPT) approaches for targeted cancer treatment. Deficiency or absence of this enzyme in certain fungi confers resistance to 5-fluorocytosine. The most well-studied fungal form is encoded by the FCY1 gene in Saccharomyces cerevisiae[1][2][3][4].
Catalyzes conversion of cytosine to uracil Catalyzes conversion of 5-fluorocytosine (5-FC, a prodrug) to 5-fluorouracil (5-FU, a cytotoxic agent)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytosine deaminase (fungal).